CymaBay Therapeutics, Inc. Reports annual revenue of $31.1 million
Company Records $105,370,000.0 loss
By USInMinutes
Published - Feb 29, 2024, 04:44 AM ET
Last Updated - May 08, 2024, 12:55 PM EDT
CymaBay Therapeutics, Inc. [CBAY] has reported $31.1 million in revenue for year ended Dec 31, 2023.
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $105,370,000.0 .
Based in Newark, California, CymaBay Therapeutics, Inc. operates in the Manufacturing sector.
